The Super Bowl of Mismanaging Congressional Investigations: Shkreli Vs. Valeant
This article was originally published in RPM Report
Executive Summary
Which is stupider: Smirking, pleading the Fifth and then calling a Congressional Committee “imbeciles” on Twitter? Or spending four hours apologizing for excessive price increases and then running two DTC commercials during the Super Bowl?
You may also be interested in...
Drug Pricing ‘Biggest Offenders’ Are Annual Increases On Widely Used Brands
Express Scripts Chief Medical Officer Steve Miller suggests that caps on annual price increases could significantly ease payer concerns over drug pricing.
Hospital Inpatient Drug Spending Up 23%, Driven By Price Increases
Older drugs and high-volume drugs contributed substantially to the increases, study conducted on behalf of hospital trade groups finds.
At Drug Pricing Hearing, Innovator Companies Mainly Escape Congressional Wrath
Members of House Oversight Committee accuse Turing and Valeant of 'trashing' mainstream innovator companies with their drug pricing practices.